Advertisement

Topics

Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

17:00 EST 16 Feb 2017 | News-Medical.net

Genomic testing of biopsies from patients with deadly, treatment-resistant cancerous blood syndromes called histiocytoses allowed doctors to identify genes fueling the ailments and use targeted molecular drugs to successfully treat them.

Original Article: Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes

NEXT ARTICLE

More From BioPortfolio on "Doctors use targeted molecular drugs to treat fatal cancerous blood syndromes"

Quick Search
Advertisement